Keywords: خطر متوسط; Neuroblastoma; Intermediate risk; Outcome;
مقالات ISI خطر متوسط (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: خطر متوسط; Low-dose-rate; Androgen deprivation therapy; Biochemical control; Intermediate risk; Prostate cancer; Brachytherapy;
Keywords: خطر متوسط; Endometrial cancer; Intermediate risk; Adjuvant therapy; Radiotherapy; NCDB;
Keywords: خطر متوسط; Non-muscle-invasive bladder cancer; Intermediate risk; Bacillus Calmette-Guérin; BCG;
Keywords: خطر متوسط; Prostate; Cancer; Active surveillance; Intermediate risk;
Keywords: خطر متوسط; Germ cell tumors; Intermediate risk; Prognosis; Survival; Testicular cancer;
Keywords: خطر متوسط; stentless aortic prosthesis; transcatheter aortic valves; small aortic annulus; haemodynamics; intermediate risk; AVR; aortic valve replacement; CI; confidence interval; FS; Freedom SOLO; OR; odds ratio; PARTNER; Placement of Aortic Transcatheter Valves;
Keywords: خطر متوسط; CCyR; complete cytogenetic response; CML; chronic myeloid leukemia; G-CSF; granulocyte-colony stimulating factor; GM-CSF; granulocyte-monocyte-colony stimulating factor; HR; high risk; IL; interleukin; INF; interferon; IR; intermediate risk; LR; low risk;
Keywords: خطر متوسط; Brachytherapy; Radiation therapy; Prostate cancer; Intermediate risk;
Keywords: خطر متوسط; oral tongue squamous cell carcinoma (OTSCC); perineural invasion; vascular invasion; intermediate risk
Keywords: خطر متوسط; Testicular cancer; Germ cell tumor; Intermediate Risk; Survival; Prognosis;
Keywords: خطر متوسط; Non-muscle-invasive bladder cancer; Risk groups; Intermediate risk; Low risk; Treatment;
Keywords: خطر متوسط; Prostate cancer; Intermediate risk; HDR brachytherapy; PSA bounce; Biochemical failure;
Keywords: خطر متوسط; urinary bladder neoplasms; mycobacterium bovis; administration; intravesical; chemotherapy; adjuvant; risk; AUA; American Urological Association; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Club Urologico Espanol de Tratamiento Oncologi
Keywords: خطر متوسط; Prostate cancer; Intermediate risk; Dose escalation; Androgen deprivation; Risk stratification;
National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate?
Keywords: خطر متوسط; prostatic neoplasms; watchful waiting; prostatectomy; neoplasm recurrence; local; risk factors; AS; active surveillance; FIR; favorable IR; GG; Grade Group; IR; intermediate risk; LR; low risk; MRI; magnetic resonance imaging; NCCN®; National Comprehensi
Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer
Keywords: خطر متوسط; Prostate cancer; Brachytherapy; Intermediate risk;
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?
Keywords: خطر متوسط; mRCC; Intermediate risk; Overall survival; Poor risk; Sunitinib;
Transcatheter aortic valve implantation: Update in 2018
Keywords: خطر متوسط; Transcatheter aortic valve implantation; Intermediate risk; Pacemaker implantation; Paravalvular leak; VARC;
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis
Keywords: خطر متوسط; ETV6/RUNX1-positive ALL; Childhood leukemia; FISH; ETV6/RUNX1 fusion gene; Cytogenetics; ALL; acute lymphoblastic leukemia; EFS; event-free survival; OS; overall survival; RFS; relapse-free survival; BM; bone marrow; SUB; subclones; mSUB; minor subclones;
Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review
Keywords: خطر متوسط; Clinical stage; Downstaging; Gleason 3 + 4; Gleason 4 + 3; Intermediate risk; Prostate cancer; Prostate-specific antigen; Prognosis; Upstaging;
Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk: Results from the Nordic Lotus-TAVR registry
Keywords: خطر متوسط; Aortic valve stenosis; Transcatheter aortic valve replacement; Intermediate risk; Safety; Efficacy;
Permanent prostate brachytherapy and short-term androgen deprivation for intermediate-risk prostate cancer in Japanese men: Outcome and toxicity
Keywords: خطر متوسط; Anti-androgen deprivation therapy; Brachytherapy; Intermediate risk; Prostate cancer;
Age, Comorbidity, and the Risk of Prostate Cancer-Specific Mortality in Men With Biopsy Gleason Score 4+3: Implications on Patient Selection for Multiparametric MRI
Keywords: خطر متوسط; Intermediate risk; MRI; Occult cancer; Older age: Prostate cancer;
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study
Keywords: خطر متوسط; aortic stenosis; implantation; intermediate risk; transcatheter aortic valve; AS; aortic stenosis; CABG; coronary artery bypass grafting; MACCE; major adverse cardiac and cerebrovascular event(s); PPM; permanent pacemaker; RCT; randomized controlled trial
Intérêt du coroscanner en urgence pour l’exclusion de la maladie coronaire chez les patients souffrant de douleur thoracique à risque faible ou intermédiaire
Keywords: خطر متوسط; Douleur thoracique; Maladie coronaire; Urgence; Risque faible; Risque intermédiaire; Scanner coronaireChest pain; Coronary artery disease; Emergency; Low risk; Intermediate risk; CCTA
Prognostic value of adenosine stress perfusion cardiac MRI with late gadolinium enhancement in an intermediate cardiovascular risk population
Keywords: خطر متوسط; Cardiac magnetic resonance; Stress perfusion; Adenosine; Prognosis; Ischaemia; Intermediate risk;
Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial brachytherapy monotherapy
Keywords: خطر متوسط; Prostate cancer; Intermediate risk; Brachytherapy;
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - Long-term results of trial ALL-REZ BFM P95/96
Keywords: خطر متوسط; Acute lymphoblastic leukaemia; Relapse; Childhood; MRD; Prognosis; Intermediate risk; Stratification;
Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy
Keywords: خطر متوسط; Prostate cancer; Intermediate risk; High risk; Gleason sum; Outcomes;
Ãtude comparative des résultats carcinologiques après prostatectomie et radiothérapie externe (75,6 Gy) avec hormonothérapie concomitante pour cancer de prostate à risque intermédiaire de D'Amico
Keywords: خطر متوسط; Cancer de prostate; Risque intermédiaire; Prostatectomie totale; Radiothérapie externe; Hormonothérapie; Prostate cancer; Intermediate risk; Radical prostatectomy; External beam radiotherapy; Short hormonotherapy;
Risk Stratification Using Computed Tomography Coronary Angiography in Patients Undergoing Intermediate-Risk Noncardiac Surgery
Keywords: خطر متوسط; computed tomography coronary angiography; coronary artery calcium score; intermediate risk; noncardiac surgery; preoperative cardiovascular riskACC/AHA, American College of Cardiology/American Heart Association; AUC, area under the curve; AUCCCT, Appropri
Impact of Primary Gleason Grade on Risk Stratification for Gleason Score 7 Prostate Cancers
Keywords: خطر متوسط; Gleason grade; Intermediate risk; Brachytherapy; Radiation planning;
Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia
Keywords: خطر متوسط; ALL; acute lymphoblastic leukemia; MRD; minimal residual disease; FCM; flow cytometry; BM; bone marrow; LR; low risk; IR; intermediate risk; HR; high risk; EFS; event-free survival; RFS; relapse-free survival; CR; complete remission; CCR; continuous compl
High-Dose Radiotherapy With or Without Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer: Cancer Control and Toxicity Outcomes
Keywords: خطر متوسط; Prostate cancer; Androgen deprivation therapy; Intermediate risk; Dose-escalated radiotherapy; Biochemical control;
Effect of Radiotherapy Techniques (IMRT vs. 3D-CRT) on Outcome in Patients With Intermediate-Risk Rhabdomyosarcoma Enrolled in COG D9803-A Report From the Children's Oncology Group
Keywords: خطر متوسط; Rhabdomyosarcoma; Intermediate risk; Intensity-modulated radiotherapy; Three-dimensional conformal radiotherapy; IMRT; 3D-CRT;
Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiation Therapy in the Treatment of Intermediate-Risk Prostate Cancer - Long Term Results
Keywords: خطر متوسط; Prostate cancer; High-dose-rate brachytherapy; Hypofractionation; Prostate biopsy; Intermediate risk; Biochemical failure;
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy
Keywords: خطر متوسط; Prostate cancer; Intermediate risk; Intraductal carcinoma; Radiotherapy; Hormone therapy; Prognosis; Metastatic disease; Clinical progression
Breast cancer screening in high risk populations
Keywords: خطر متوسط; Screening; High risk; Intermediate risk; Magnetic resonance imaging; Breast cancerCribado; Alto riesgo; Riesgo intermedio; Resonancia magnética; Cáncer de mama
Abordaje en el cribado de cáncer mamario en grupos poblacionales de riesgo elevado
Keywords: خطر متوسط; Cribado; Alto riesgo; Riesgo intermedio; Resonancia magnética; Cáncer de mama; Screening; High risk; Intermediate risk; Magnetic resonance imaging; Breast cancer;
The significance of surgical staging in intermediate-risk endometrial cancer
Keywords: خطر متوسط; Endometrial cancer; Surgical staging; Chemotherapy; Intermediate risk; High risk; Nodal metastases
Tailoring adjuvant radiotherapy for stage IB–IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score
Keywords: خطر متوسط; Cervical cancer; Intermediate risk; Small field; Radiotherapy; Node negative; GOG score
Low-density lipoprotein particle number predicts coronary artery calcification in asymptomatic adults at intermediate risk of cardiovascular disease
Keywords: خطر متوسط; Advance lipid testing; Calcium score test; Coronary artery calcification; Intermediate risk; Lipoproteins; LDL particle number; Preventative testing
Who Is the High-Risk Recipient? Predicting Mortality After Heart Transplant Using Pretransplant Donor and Recipient Risk Factors
Keywords: خطر متوسط; ER; elevated risk; HR; high risk; IR; intermediate risk; LR; low risk; MR; moderate risk; ROC; receiver operating characteristic; RSS; risk stratification score; SSLR; stratum specific likelihood ratio; 34;
Évolution clinique des patients atteints d’un cancer prostatique de risque intermédiaire traités par implants permanents d’iode-125 : l’expérience de l’Hôtel-Dieu de Québec
Keywords: خطر متوسط; Curiethérapie; Prostate; Planification intra-opératoire; Risque intermédiaire; MonothérapieBrachytherapy; Prostate; Intra-operative; Intermediate risk; Monotherapy
Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate- and High-Risk Clinically Localized Prostate Cancer: A Postrandomization Analysis by Risk Group
Keywords: خطر متوسط; Prostate cancer; Risk groups; Intermediate risk; High risk; Comorbidity; Androgen suppression therapy; Radiation; Randomized trial;
Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy
Keywords: خطر متوسط; Prostate cancer; Brachytherapy; Intermediate risk;
Selecting Patients for Exclusive Permanent Implant Prostate Brachytherapy: The Experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital Group on 809 Patients
Keywords: خطر متوسط; Prostate cancer; Brachytherapy; Permanent implant; Intermediate risk;
Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
Keywords: خطر متوسط; Endometrial cancer; Intermediate risk; Adjuvant radiotherapy; Adjuvant chemotherapy; Cisplatin-based chemotherapy
A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia
Keywords: خطر متوسط; HIT; heparin-induced thrombocytopenia; PF4; platelet factor 4; LR; low risk; IR; intermediate risk; HR; high risk; ELISA; enzyme-linked immunosorbent assays; PPV; positive predictive value; NPV; negative predictive value; H/PF4; heparin/PF4; SRA; platelet